home / stock / allr / allr news

ALLR News and Press, Allarity Therapeutics Inc. From 12/01/22

Stock Information
Company Name: Allarity Therapeutics Inc.
Stock Symbol: ALLR
Market: NASDAQ
Website: allarity.com
Menu
ALLR ALLR Quote ALLR Short ALLR News ALLR Articles ALLR Message Board
Get ALLR Alerts

News, Short Squeeze, Breakout and More Instantly...
ALLR - Allarity Therapeutics Reschedules 2022 Annual Stockholders Meeting and Sets New Record Date

PRESS RELEASE Boston , MA U.S.A. ( December 1 , 2022) — Allarity Therapeutics, Inc. (“Allarity” or the “Company”), a clinical-stage pharmaceutical company developing novel oncology therapeutics together with drug-specific DRP ® ...
ALLR - Allarity Therapeutics reports Q3 results

Allarity Therapeutics press release ( NASDAQ: ALLR ): Q3 Net loss was $5.0 million for the three months ended September 30, 2022, compared to $1.4 million for the comparable period in 2021. For further details see: Allarity Therapeutics reports Q3 results

ALLR - Allarity Therapeutics Reports Third Quarter 2022 Financial Results

Press release Cambridge, MA U.S.A. (November 15, 2022) — Allarity Therapeutics, Inc. (“Allarity” or the “Company”), a clinical-stage pharmaceutical company developing novel oncology therapeutics together with drug-specific DRP ® companion ...

ALLR - Allarity Therapeutics Announces Adjournment of 2022 Annual Meeting of Stockholders

Press release Cambridge, MA U.S.A. (November 7, 2022) — Allarity Therapeutics, Inc. (“Allarity” or the “Company”), a clinical-stage pharmaceutical company developing novel oncology therapeutics together with drug-specific DRP® companion diagno...
ALLR - Precision Medicine Could Get Even More Precise With Allarity Therapeutics’ “Next-Generation” Diagnostics Platform

(NewsDirect) Once brought into its pipeline , Allarity uses its DRP® platform to develop companion diagnostics alongside each drug to improve the treatments in a personalized medicine approach. Earlier this year, the company refocused its pipeline strategy toward co...

ALLR - Precision Medicine Could Get Even More Precise With Allarity Therapeutics' "Next-Generation" Diagnostics Platform

--News Direct-- Once brought into its pipeline , Allarity uses its DRP® platform to develop companion diagnostics alongside each drug to improve the treatments in a personalized medicine approach. Earlier this year, the company refocused its pipeline strategy toward...

ALLR - Allarity Therapeutics GAAP EPS of -$0.72 misses by $0.46

Allarity Therapeutics press release ( NASDAQ: ALLR ): Q2 GAAP EPS of -$0.72 misses by $0.46 . As of June 30, 2022, Allarity’s cash was $7.7 million, as compared to $19.6 million as of December 31, 2021 Shares +4.07% . For further details see: A...
ALLR - Allarity Therapeutics Reports Second Quarter 2022 Financial Results, Provides Recent Operational Highlights, and Regains Compliance with NASDAQ Listing Requirements

Cambridge, MA U.S.A. ( October 11 , 2022) — Allarity Therapeutics, Inc. (“Allarity” or the “Company”), a clinical-stage pharmaceutical company developing novel oncology therapeutics together with drug-specific DRP ® companion diagn...

ALLR - Allarity Therapeutics Appoints Seasoned Biotechnology Executive Jerry McLaughlin to Board of Directors

Press release Cambridge, MA U.S.A. (September 26, 2022) — Allarity Therapeutics, Inc. (Nasdaq: ALLR) (“Allarity” or the “Company”), a clinical-stage pharmaceutical company developing novel oncology therapeutics together with drug-specific DRP &#x...

ALLR - Allarity Therapeutics to Present at Ladenburg Thalmann Healthcare Conference

Press release Cambridge, MA U.S.A. (September 16, 2022) — Allarity Therapeutics, Inc. (Nasdaq: ALLR) (“Allarity” or the “Company”), a clinical-stage pharmaceutical company developing novel oncology therapeutics together with drug-specific DRP &#x...
Previous 10 Next 10